Evidence map›Paper›PMID 23836905›Full record

ArticleThe Journal of biological chemistry2013

Plasticity of the quinone-binding site of the complex II homolog quinol:fumarate reductase.

Prashant K Singh, Maruf Sarwar, Elena Maklashina, Violetta Kotlyar, Sany Rajagukguk, Thomas M Tomasiak, Gary Cecchini, Tina M Iverson

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Oxidative cyclizations in orthosomycin biosynthesis expand the known chemistry of an oxygenase superfamily.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Prashant K SinghDepartment of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.
Maruf Sarwar
Elena Maklashina
Violetta Kotlyar
Sany Rajagukguk
Thomas M Tomasiak
Gary Cecchini
Tina M Iverson
San Francisco VA Medical Center · USVanderbilt University Medical Center · USUniversity of California, San Francisco · US

Funding

Structure/Function of Complex ll OxidoreductasesR01GM061606 · NIGMS · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI CECCHINI, GARY, IVERSON, T M · 2001 to 2022
$9.1M
Chemistry-Biology Interface Training GrantT32GM065086 · NIGMS · VANDERBILT UNIVERSITY · PI BACHMANN, BRIAN O, SULIKOWSKI, GARY ALLEN · 2002 to 2022
$7.0M
Complexities of complex II: A versatile architecture for respirationR01GM079419 · NIGMS · VANDERBILT UNIVERSITY · PI IVERSON, T M · 2007 to 2011
$1.3M
THE ROLE OF ACETYLATION IN MITOCHONDRIAL FUNCTIONI01BX001077 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI CECCHINI, GARY · 2011 to 2014
–
BLRD VA I01 BX001077NIGMS NIH HHS GM079419NIGMS NIH HHS GM61606NIGMS NIH HHS R01 GM061606NIGMS NIH HHS R01 GM079419NIGMS NIH HHS T32 GM065086
6 · The paper itself

Abstract

Respiratory processes often use quinone oxidoreduction to generate a transmembrane proton gradient, making the 2H(+)/2e(-) quinone chemistry important for ATP synthesis. There are a variety of quinones used as electron carriers between bioenergetic proteins, and some respiratory proteins can functionally interact with more than one quinone type. In the case of complex II homologs, which couple quinone chemistry to the interconversion of succinate and fumarate, the redox potentials of the biologically available ubiquinone and menaquinone aid in driving the chemical reaction in one direction. In the complex II homolog quinol:fumarate reductase, it has been demonstrated that menaquinol oxidation requires at least one proton shuttle, but many of the remaining mechanistic details of menaquinol oxidation are not fully understood, and little is known about ubiquinone reduction. In the current study, structural and computational studies suggest that the sequential removal of the two menaquinol protons may be accompanied by a rotation of the naphthoquinone ring to optimize the interaction with a second proton shuttling pathway. However, kinetic measurements of site-specific mutations of quinol:fumarate reductase variants show that ubiquinone reduction does not use the same pathway. Computational docking of ubiquinone followed by mutagenesis instead suggested redundant proton shuttles lining the ubiquinone-binding site or from direct transfer from solvent. These data show that the quinone-binding site provides an environment that allows multiple amino acid residues to participate in quinone oxidoreduction. This suggests that the quinone-binding site in complex II is inherently plastic and can robustly interact with different types of quinones.

Indexed as

Molecular Docking SimulationCatalytic DomainEscherichia coliEscherichia coli ProteinsKineticsOxidoreductasesStructure-Activity RelationshipUbiquinoneEscherichia coli ProteinsOxidoreductasesquinol fumarate reductaseUbiquinoneBioenergetics/Electron Transfer ComplexElectron TransferMenaquinoneNaphthoquinoneRedoxRespiratory ChainTricarboxylic Acid (TCA) CycleUbiquinone

Identifiers

PMID23836905
PMCPMC3750132
OpenAlexW1963895013

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.